Vaxcyte President, CFO Andrew Guggenhime disposes of 10,000 common shares worth $538,885
PCVX•Insider sale and option exercise
Vaxcyte President and CFO Andrew Guggenhime sold 10,000 shares on Aug. 3 at weighted-average prices of $53.76 and $54.18.
He also exercised stock options for 10,000 shares at $5.35.
Directly owned common shares fell to 105,176 following the transactions.
